Published in Drug Law Weekly, July 29th, 2008
"Herein, we report the X-ray crystallographic structure of BlaC inhibited with clavulanate at a resolution of 1.7 angstrom with an R-factor value of 0.180 and R-free value of 0.212 for the m/z + 154 clavulanate-derived fragment observed in the active site. Structural evidence reveals the presence of hydrogen bonds to the C1 carbonyl along with a coplanar arrangement of C1, C2, C3, and N4, which favors enolization to generate a trans-alpha,beta-...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.